Bigul

Pfizer drops 3% on valuation concerns

Brokerage Centrum Broking has downgraded the stock to hold from buy with a target price of Rs 3,100.
12-09-2018
Bigul

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Pfizer Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
11-09-2018
Bigul

Pfizer Limited - Annual Report For The Financial Year Ended March 31, 2018

Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith is the copy of the Annual Report of the Company for the year ended March 31, 2018.
07-09-2018
Bigul

Announcement under Regulation 30 (LODR)-Meeting Updates

Pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Members at the 67th Annual General Meeting of the Company held on Thursday, September 6, 2018 have passed a special resolution for continuation of the remaining term of Mr. R. A. Shah as an Independent Director up to November 9, 2019 with the requisite majority....
07-09-2018
Bigul

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith the scrutinizer's report on the remote e-voting and poll results for the 67th Annual General Meeting of the Company held on September 6, 2018.
07-09-2018
Bigul

Shareholder Meeting / Postal Ballot-Outcome of AGM

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed proceedings of the 67th Annual General Meeting of the Company held on September 6, 2018.
07-09-2018
Bigul

Adani Transmission, Pfizer drop on ASM inclusion

The securities which are placed under the ASM framework would be reviewed on bimonthly or periodic basis, the NSE said in a circular.
30-08-2018
Bigul

Clarification

With reference to increase in volume, Pfizer Ltd has submitted to BSE a copy of Clarification is enclosed.
27-08-2018
Bigul

Clarification sought from Pfizer Ltd

The Exchange has sought clarification from Pfizer Ltd on August 27, 2018, with reference to increase in volume.The reply is awaited.
27-08-2018
Bigul

Announcement under Regulation 30 (LODR)-Change in Management

Pursuant to Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that Mr. Milind Patil has been appointed as the Chief Financial Officer of the Company effective August 16, 2018.
16-08-2018
Next Page
Close

Let's Open Free Demat Account